Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;38(4):918-922.
doi: 10.1038/s41375-024-02180-3. Epub 2024 Feb 17.

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

Marie Sébert  1   2   3 , Lucie Freiman  4 , Cendrine Chaffaut  5 , Agnès Guerci  6   7 , Pierre Peterlin  6   8 , Sylvain Thépot  6   9 , Odile Beyne-Rauzy  6   10 , Sophie Park  6   11 , Thomas Cluzeau  6   12 , Fatiha Chermat  6 , Pierre Fenaux  13   4   6 , Claude Preudhomme  14 , Emmanuelle Clappier  13   15 , Sylvie Chevret  5 , Lionel Adès  13   4   6 , Nicolas Duployez  13   14   15 , Matthieu Duchmann  16   17
Affiliations

Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens

Marie Sébert et al. Leukemia. 2024 Apr.
No abstract available

PubMed Disclaimer

References

    1. Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 2022;1:1–14. - DOI
    1. Aguirre LE, Al Ali N, Sallman DA, Ball S, Jain AG, Chan O, et al. Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes. Leukemia. 2023;37:1530–9. - DOI - PubMed
    1. Baer C, Huber S, Hutter S, Meggendorfer M, Nadarajah N, Walter W, et al. Risk prediction in MDS: independent validation of the IPSS-M-ready for routine? Leukemia. 2023;37:938–41. - DOI - PubMed - PMC
    1. Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao L-P, et al. Real-world validation of molecular international prognostic scoring system for myelodysplastic syndromes. J Clin Oncol J Am Soc Clin Oncol. 2023;41:2827–42. - DOI
    1. Huber S, Haferlach T, Müller H, Meggendorfer M, Hutter S, Hoermann G, et al. MDS subclassification—do we still have to count blasts? Leukemia. 2023;37:942–5. - DOI - PubMed - PMC